Lorem ipsum dolor sit

amet consectetur adipisicing elit.

Porro obcaecati cupiditate sequi voluptatem eos laborum modi ipsa, repellat voluptate vero, quo autem fugiat in quis? Commodi aliquam doloribus corrupti inventore.

Lorem ipsum dolor sit

amet consectetur adipisicing elit.

Porro obcaecati cupiditate sequi voluptatem eos laborum modi ipsa, repellat voluptate vero, quo autem fugiat in quis? Commodi aliquam doloribus corrupti inventore.

Webinar Details

Date and Time

March 7th, 2024 from 12:00 - 1:00 p.m ET

Webinar Overview

Following the recent publication of CPS’ third annual health system specialty pharmacy (HSSP) Patient Impact Report, an expert panel will take a deep dive into this year’s biggest topics and newest insights.

Attendees will discover actionable opportunities to enhance patient care and clinical outcomes while furthering strategic growth through HSSP services.

Featured Discussion Topics

Importance of and trends in HSSP clinical outcomes & measurement
Ways HSSPs are addressing social determinants of health
Role of technology in supporting HSSP clinical outcomes and reporting
How to leverage clinical and patient impact data to demonstrate HSSP value to stakeholders

Click below to register for the webinar.

Webinar: Elevating HSSP Patient Impact in 2024 & Beyond

March 7th, 2024 | 12:00 - 1:00 p.m. ET

How Does Your Hospital Pharmacy Benefit?

IN-DEPTH ASSESSMENTS We review clinical and financial performance, regulatory requirements, compliance status, standards of practice, accreditation standards, policies and procedures, and more

GUIDANCE BY PHARMACY PRACTICE SPECIALISTS We advise your pharmacy while addressing performance barriers and introducing a culture of continuous improvement

CORRECTIVE ACTION PLANS We benchmark performance and identify opportunities

SPECIAL COMPLIANCE PROGRAM We deliver keen focus on 340B programs, USP 797/800, controlled substance risk, accreditation readiness, and more

LEVERAGE OUR YEARS OF EXPERIENCE CPS has delivered over 250 customized sterile compounding consultative assessments for diverse compounding operations

RECEIVE A COMPLETE SITE ASSESSMENT using our proprietary audit tool

RECEIVE A DETAILED EVALUATION OF STAFF AND SYSTEMS including personnel training and evaluation, an operational review, and more

FOLLOWING ASSESSMENT, CPS will deliver a written compliance report and a corrective action plan detailing findings and recommendations to bring your compounding pharmacy into regulatory compliance.

CPS WORKS WITH YOUR THIRD-PARTY ADMINISTRATORS to capture the claims which now meet the standards for inclusion in your 340B program

YOUR ORGANIZATIONAL REVENUE INCREMENTALLY IMPROVES FROM THIS PROCESS

Lorem ipsum dolor

sit amet consectetur adipisicing elit. Dignissimos, tenetur voluptatibus! Culpa iure rerum nemo quibusdam inventore reiciendis alias facere.

Lorem Ipsum

Lorem

Lorem Ipsum

Lorem

Lorem Ipsum

Missed the 2024 Patient Impact Report?

Click the button below to download the PDF.

DOWNLOAD

Webinar Speakers

Jessica Mourani, PharmD
Director, Clinical Outcomes | CPS

Jessica is the clinical pharmacist who oversees the CPS Outcomes team’s research initiatives across CPS clients’ specialty sites. Through this research, she and the team have developed the framework for reporting on and highlighting our clinical protocols for sites to deliver optimized and high touch model for sites to deliver consistent patient care with a focus on improved clinical outcomes. Jessica has presented their findings, and been awarded, at various national conferences, participated in expert panel discussions, and contributed to articles in major publications.

Brandon Newman, PharmD, MMHC, CSP
Executive Vice President & Chief Operating Officer, Specialty Solutions | CPS

Brandon is responsible for delivering outstanding specialty services to CPS client health systems and their patients by ensuring best-in-class clinical results, patient satisfaction, operational effectiveness, and financial performance. Currently, he serves as Chairman of the Specialty Pharmacy Certification Board (SPCB) and a Board Member of the National Association of Specialty Pharmacy (NASP).

Susan Trieu, PharmD
Senior Vice President, Specialty Clinical Strategy & Trend | CPS

Susan brings over 20 years of experience in pharmacy benefits management, specialty pharmacy, and the pharmaceutical industry. At CPS, she works with partnering health systems to provide strategic leadership and valued insight regarding the specialty drug pipeline. Susan’s expertise has been featured in many publications across industry organizations, such as AMCP and ASHP.